Mingze Qin

784 total citations
45 papers, 624 citations indexed

About

Mingze Qin is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Mingze Qin has authored 45 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Organic Chemistry, 22 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Mingze Qin's work include Cancer Mechanisms and Therapy (10 papers), Synthesis and biological activity (8 papers) and Cancer therapeutics and mechanisms (7 papers). Mingze Qin is often cited by papers focused on Cancer Mechanisms and Therapy (10 papers), Synthesis and biological activity (8 papers) and Cancer therapeutics and mechanisms (7 papers). Mingze Qin collaborates with scholars based in China, United Kingdom and Switzerland. Mingze Qin's co-authors include Ping Gong, Yanfang Zhao, Yunlei Hou, Yajing Liu, Hongbo Xie, Di Wu, Ye Tian, Yangyang Meng, Qi Cao and Jun Xie and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Cell Death and Differentiation.

In The Last Decade

Mingze Qin

43 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingze Qin China 16 299 243 219 73 52 45 624
Yunlei Hou China 17 427 1.4× 254 1.0× 129 0.6× 40 0.5× 46 0.9× 64 734
Kevin Currie United States 8 460 1.5× 259 1.1× 64 0.3× 87 1.2× 47 0.9× 10 755
Danny Hsu United States 12 184 0.6× 214 0.9× 117 0.5× 32 0.4× 19 0.4× 27 510
Samir Mehndiratta Taiwan 17 384 1.3× 363 1.5× 110 0.5× 27 0.4× 19 0.4× 28 744
Kai Yuan China 13 168 0.6× 218 0.9× 199 0.9× 61 0.8× 42 0.8× 36 603
Matthew Labenski United States 12 200 0.7× 405 1.7× 166 0.8× 70 1.0× 96 1.8× 20 701
Shigeki Kashimoto Japan 14 243 0.8× 339 1.4× 185 0.8× 118 1.6× 46 0.9× 21 733
Sung Yun Cho South Korea 15 277 0.9× 356 1.5× 115 0.5× 81 1.1× 35 0.7× 43 673
Wenjian Min China 14 82 0.3× 255 1.0× 190 0.9× 62 0.8× 40 0.8× 36 507
Alexandra E. Stacy Australia 7 161 0.5× 318 1.3× 472 2.2× 40 0.5× 54 1.0× 8 779

Countries citing papers authored by Mingze Qin

Since Specialization
Citations

This map shows the geographic impact of Mingze Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingze Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingze Qin more than expected).

Fields of papers citing papers by Mingze Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingze Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingze Qin. The network helps show where Mingze Qin may publish in the future.

Co-authorship network of co-authors of Mingze Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Mingze Qin. A scholar is included among the top collaborators of Mingze Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingze Qin. Mingze Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Wei, et al.. (2025). Inverse Agonists of Peroxisome Proliferator-Activated Receptor Gamma: Advances and Prospects in Cancer Treatment. Journal of Medicinal Chemistry. 68(9). 9084–9100.
2.
Qin, Mingze, Yang Su, Xiaolan Wang, et al.. (2025). Microscopic damage evolution and physical–mechanical behavior of high-temperature red sandstone under varying heating and cooling durations. Scientific Reports. 15(1). 3942–3942. 2 indexed citations
3.
Yang, Yuan, Yidong Wang, Jiwei Gao, et al.. (2024). The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor. EMBO Molecular Medicine. 16(4). 885–903. 5 indexed citations
4.
Meng, Yangyang, Yidong Wang, Shaopeng Zhang, et al.. (2023). Novel 4-Arylindolines Containing a Pyrido[3,2-d]pyrimidine Moiety as the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction Inhibitors for Tumor Immunotherapy. Journal of Medicinal Chemistry. 66(17). 11815–11830. 6 indexed citations
5.
Liu, Yajing, et al.. (2023). Agents for the Treatment of Gout: Current Advances and Future Perspectives. Journal of Medicinal Chemistry. 66(21). 14474–14493. 24 indexed citations
6.
Li, Zhiwei, Jiuyu Liu, Yue Hao, et al.. (2023). Design, synthesis, and biological evaluation of novel dihydropteridone derivatives possessing oxadiazoles moiety as potent inhibitors of PLK1. European Journal of Medicinal Chemistry. 251. 115242–115242. 8 indexed citations
7.
8.
Qin, Mingze, Yangyang Meng, Lei Liu, et al.. (2021). Discovery of 4-Arylindolines Containing a Thiazole Moiety as Potential Antitumor Agents Inhibiting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction. Journal of Medicinal Chemistry. 64(9). 5519–5534. 46 indexed citations
9.
Wu, Xia, Yangyang Meng, Lei Liu, et al.. (2021). Insights into non-peptide small-molecule inhibitors of the PD-1/PD-L1 interaction: Development and perspective. Bioorganic & Medicinal Chemistry. 33. 116038–116038. 14 indexed citations
10.
Qin, Mingze, Ye Tian, Qi Cao, et al.. (2020). Structural modifications of indolinones bearing a pyrrole moiety and discovery of a multi-kinase inhibitor with potent antitumor activity. Bioorganic & Medicinal Chemistry. 28(11). 115486–115486. 8 indexed citations
11.
Han, Yufei, Desheng Huang, Lingling Li, et al.. (2020). Ligand-based optimization to identify novel 2-aminobenzo[d]thiazole derivatives as potent sEH inhibitors with anti-inflammatory effects. European Journal of Medicinal Chemistry. 212. 113028–113028. 10 indexed citations
12.
Dong, Yuhong, Hao Hu, Yuwei Sun, et al.. (2020). Design, synthesis and biological evaluation of novel c-Met/HDAC dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(23). 127610–127610. 16 indexed citations
13.
Han, Yufei, Ye Tian, Ruxin Wang, et al.. (2020). Design, synthesis and biological evaluation of thieno[3,2-d]pyrimidine derivatives containing aroyl hydrazone or aryl hydrazide moieties for PI3K and mTOR dual inhibition. Bioorganic Chemistry. 104. 104197–104197. 22 indexed citations
14.
Qin, Mingze, Qi Cao, Ye Tian, et al.. (2019). Discovery of [1,2,4]Triazolo[4,3-a]pyridines as Potent Inhibitors Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction. Journal of Medicinal Chemistry. 62(9). 4703–4715. 82 indexed citations
15.
Li, Yingxiu, Tian-Yu Ye, Le Xu, et al.. (2019). Discovery of 4-piperazinyl-2-aminopyrimidine derivatives as dual inhibitors of JAK2 and FLT3. European Journal of Medicinal Chemistry. 181. 111590–111590. 22 indexed citations
16.
Qin, Mingze, Qi Cao, Xia Wu, et al.. (2019). Discovery of the programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing an indoline scaffold. European Journal of Medicinal Chemistry. 186. 111856–111856. 45 indexed citations
17.
Yang, Yifeng, Yingxiu Li, Yunlei Hou, et al.. (2019). Design, synthesis, and biological evaluation of 4-phenoxyquinoline derivatives as potent c-Met kinase inhibitor. Bioorganic & Medicinal Chemistry Letters. 29(23). 126666–126666. 16 indexed citations
18.
Yang, Yifeng, Yingxiu Li, Yinliang Qi, et al.. (2019). Optimization of biaryloxazolidinone as promising antibacterial agents against antibiotic-susceptible and antibiotic-resistant gram-positive bacteria. European Journal of Medicinal Chemistry. 185. 111781–111781. 16 indexed citations
19.
Liu, Yajing, Zexin Hong, Daiying Zuo, et al.. (2018). Synthesis and biological evaluation of 4,6-diphenyl-2-(1H-pyrrol-1-yl)nicotinonitrile analogues of crolibulin and combretastatin A-4. European Journal of Medicinal Chemistry. 146. 185–193. 16 indexed citations
20.
Qin, Mingze, Ye Tian, Simiao Yu, et al.. (2017). Novel methyl indolinone-6-carboxylates containing an indole moiety as angiokinase inhibitors. European Journal of Medicinal Chemistry. 139. 492–502. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunlei Hou Breakdown of academic impact, for papers by Kevin Currie Breakdown of academic impact, for papers by Danny Hsu Breakdown of academic impact, for papers by Samir Mehndiratta Breakdown of academic impact, for papers by Kai Yuan Breakdown of academic impact, for papers by Matthew Labenski Breakdown of academic impact, for papers by Shigeki Kashimoto Breakdown of academic impact, for papers by Sung Yun Cho Breakdown of academic impact, for papers by Wenjian Min Breakdown of academic impact, for papers by Alexandra E. Stacy
Rankless by CCL
2026